It’s PharmaGeddon: more than half of biotechs in cash crisis
Nick Evans
Tuesday, 4 November 2008
MORE than half of the small life science companies that report quarterly cash statements have less than a year’s funding left, and 70% have less than 18 months, as at the end of the last quarter.
Security Description MktCap($) Time to Empty (Yrs) Reported Cash Notes
AOP Apollo Life Sciences 7.6 In Administration
GIA Giaconda Limited 9.6 -0.02 $28,000 $40 million raise recently collapsed
NLS Narhex Life Sciences 3.1 -0.02 $10,000 Suspended from trading in March
MVU MatrixView Limited 27.9 -0.05 $149,927
PCC Probiomics Limited 0.7 -0.05 $82,000 Ann plans to raise $500K
MGZ Medigard Limited 4.1 -0.05 $30,000
BNE Bone Medical Limited 25.0 -0.07 $185,061 Plans to raise $1.5 million
DIA Dia-B Tech Limited 1.8 -0.08 $221,000
MVH Medic Vision Limited 6.1 -0.09 $256,000 Underwritten $1 million raise underway
IMI IM Medical Ltd 6.2 -0.10 $395,000 Has $5 million
PLD Portland Orthopaed. 2.7 -0.12 $886,000
EMS Eastland Medical 24.7 -0.15 $397,000
STC Stem Cell Sciences 6.0 -0.16 $1,636,000
SLA Solagran Limited 43.7 -0.19 $1,056,000 Announced $2 million raise
TIS Tissue Therapies 4.9 -0.19 $733,000
STI Stirling Products 1.9 -0.20 $493,000
ACU Avantogen Limited 22.6 -0.23 $403,000
BOS Biosignal Limited 3.4 -0.23 $708,565
RBY Rockeby Biomed Ltd 1.5 -0.25 $291,000 Grant funding of $800K, plus raising up to $750K
NAL Norwood Abbey Ltd 1.7 -0.26 $314,000
BMI Bmdi Intl Ltd 8.5 -0.27 $149,000
CAU CollTech Australia 1.8 -0.28 $659,966
RTL RTL Corp 2.3 -0.28 $299,000
MTY Medical Therapies 5.2 -0.28 $490,000 $2 million funding
KSX Karmelsonix Ltd 6.2 -0.28 $1,836,000 Has $7 million credit line
HTX Healthlinx Limited 4.7 -0.31 $535,000 Issuing $250K convertible notes
BLT Benitec Limited 16.6 -0.34 $1,069,000 Recently raised $1.9 million
OMI Occupational & Med. 10.4 -0.39 $670,000
NEU Neuren Pharmaceut. 12.9 -0.40 $4,419,000
VLA Viralytics Limited 12.7 -0.47 $1,853,000
ICV Incitive Limited 1.1 -0.48 $553,000
PYC Phylogica Limited 10.0 -0.50 $2,150,000
GBL Genesis Biomedical 1.9 -0.51 $699,000
PRR Prima Biomed Ltd 2.1 -0.54 $749,000
XCD Xceed Capital Ltd. 4.0 -0.57 $2,500,000
ANQ Anaeco Limited 7.8 -0.58 $1,006,000
BIT Biotron Limited 9.5 -0.60 $1,456,000
AQL AquaCarotene Limited 2.4 -0.62 $642,000
PNO PharmaNet Group 1.6 -0.62 $406,556
ALT Analytica Limited 5.6 -0.68 $700,000
AVX Avexa Limited 46.7 -0.80 $33,020,000
SLT Select Vaccines 1.3 -0.81 $849,000
IPD Impedimed Limited 53.7 -0.82 $9,137,000
MDV Medivac Limited 4.0 -0.83 $1,628,952
SBN Sun Biomedical Ltd 7.7 -0.84 $1,742,000
OBJ OBJ Limited 2.6 -0.85 $1,158,000
SPL Starpharma Holdings 44.9 -0.86 $6,229,000
GBI Genera Biosystems 5.5 -0.87 $3,243,000
ACL Alchemia Limited 24.9 -0.94 $12,309,000
PXL Proteome Systems Ltd 14.9 -0.98 $8,357,000
- Forums
- ASX - By Stock
- SBN
- it’s pharmageddon
it’s pharmageddon
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online